Malaria Chemoprevention in the Postdischarge Management of Severe Anemia.
暂无分享,去创建一个
Duolao Wang | C. John | S. Kariuki | K. Otieno | M. Desai | B. Robberstad | R. Opoka | R. Idro | K. Phiri | A. Samuels | Nickline Kuya | M. Boele van Hensbroek | A. Dhabangi | T. Kwambai | V. Watson | F. T. ter Kuile | E. D. Onyango | Aaron M. Samuels | E. Onyango | Titus K. Kwambai
[1] J. Walson,et al. Seeking interventions to reduce post-discharge mortality among children in sub-Saharan Africa. , 2019, The Lancet. Global health.
[2] K. Maitland,et al. Co-trimoxazole or multivitamin multimineral supplement for post-discharge outcomes after severe anaemia in African children: a randomised controlled trial , 2019, The Lancet. Global health.
[3] K. Maitland,et al. Immediate Transfusion in African Children with Uncomplicated Severe Anemia. , 2019, The New England journal of medicine.
[4] K. Maitland,et al. Transfusion Volume for Children with Severe Anemia in Africa. , 2019, The New England journal of medicine.
[5] Steve M. Taylor,et al. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. , 2019, The Lancet. Infectious diseases.
[6] D. Havlir,et al. Monthly sulfadoxine–pyrimethamine versus dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial , 2019, The Lancet.
[7] B. Blomberg,et al. Introducing post-discharge malaria chemoprevention (PMC) for management of severe anemia in Malawian children: a qualitative study of community health workers’ perceptions and motivation , 2018, BMC Health Services Research.
[8] Duolao Wang,et al. Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial , 2018, Trials.
[9] B. Robberstad,et al. Post-discharge malaria chemoprevention (PMC) in Malawi: caregivers` acceptance and preferences with regard to delivery methods , 2018, BMC Health Services Research.
[10] L. Okell,et al. Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa , 2017, Scientific Reports.
[11] A. York. Seasonal malaria chemoprevention in the Sahel. , 2017, The Lancet. Infectious diseases.
[12] M. Karlsson,et al. Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine , 2017, Antimicrobial Agents and Chemotherapy.
[13] A. Stergachis,et al. Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis , 2017, The Lancet. Infectious diseases.
[14] P. Bangirana,et al. High Postdischarge Morbidity in Ugandan Children With Severe Malarial Anemia or Cerebral Malaria , 2016, Journal of the Pediatric Infectious Diseases Society.
[15] N. Kissoon,et al. Postdischarge mortality in children with acute infectious diseases: derivation of postdischarge mortality prediction models , 2015, BMJ Open.
[16] K. Maitland,et al. Anaemia and blood transfusion in African children presenting to hospital with severe febrile illness , 2015, BMC Medicine.
[17] P. Rosenthal,et al. Protective Efficacy and Safety of Three Antimalarial Regimens for the Prevention of Malaria in Young Ugandan Children: A Randomized Controlled Trial , 2014, PLoS medicine.
[18] E. Purssell,et al. Does the Use of Dihydroartemisinin-Piperaquine in Treating Patients with Uncomplicated falciparum Malaria Reduce the Risk for Recurrent New falciparum Infection More Than Artemether-Lumefantrine? , 2014, Malaria research and treatment.
[19] Seth R Flaxman,et al. A systematic analysis of global anemia burden from 1990 to 2010. , 2014, Blood.
[20] B. Faragher,et al. Intermittent preventive therapy for malaria with monthly artemether-lumefantrine for the post-discharge management of severe anaemia in children aged 4-59 months in southern Malawi: a multicentre, randomised, placebo-controlled trial. , 2012, The Lancet. Infectious diseases.
[21] K. Maitland,et al. Changing trends in blood transfusion in children and neonates admitted in Kilifi District Hospital, Kenya , 2010, Malaria Journal.
[22] D. Conway,et al. A Randomised Trial to Compare the Safety, Tolerability and Efficacy of Three Drug Combinations for Intermittent Preventive Treatment in Children , 2010, PloS one.
[23] D. Conway,et al. Prevention of the Recurrence of Anaemia in Gambian Children Following Discharge from Hospital , 2010, PloS one.
[24] B. Cissé,et al. Randomized Trial of Piperaquine with Sulfadoxine-Pyrimethamine or Dihydroartemisinin for Malaria Intermittent Preventive Treatment in Children , 2009, PloS one.
[25] F. Binka,et al. Seasonal Intermittent Preventive Treatment for the Prevention of Anaemia and Malaria in Ghanaian Children: A Randomized, Placebo Controlled Trial , 2008, PloS one.
[26] J. Vulule,et al. Causes of deaths using verbal autopsy among adolescents and adults in rural western Kenya , 2008, Tropical medicine & international health : TM & IH.
[27] M. Molyneux,et al. Long Term Outcome of Severe Anaemia in Malawian Children , 2008, PloS one.
[28] D. Kwiatkowski,et al. Research Article ( New England Journal of Medicine ) Severe anemia in Malawian children , 2016 .
[29] F. T. Ter Kuile,et al. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. , 2007, JAMA.
[30] B. Cissé,et al. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial , 2006, The Lancet.
[31] R. Steketee,et al. Longitudinal evaluation of severely anemic children in Kenya: the effect of transfusion on mortality and hematologic recovery , 1997, AIDS.
[32] K. Bojang,et al. Management of severe malarial anaemia in Gambian children. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[33] O. Rodrigues,et al. Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria , 1997, British journal of haematology.
[34] B. Metchock,et al. Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens. , 1996, The American journal of tropical medicine and hygiene.
[35] A. V. Peterson,et al. On the regression analysis of multivariate failure time data , 1981 .